Afrika Selatan - Inggris - South African Health Products Regulatory Authority (SAHPRA)

pharma-q holdings (pty) ltd - #n/a - not indicated - none

Malta - Inggris - Medicines Authority

essential pharma ltd (malta) vision exchange building, triq it-territorjals, zone central business district birkirkara, cbd 1070, malta - eye drops, solution - apraclonidine 5 mg/ml - ophthalmologicals

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

essential pharma ltd - lofepramine hydrochloride - oral suspension - 14mg/1ml

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

essential pharma ltd - imipramine hydrochloride - oral solution - 5mg/1ml

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

essential pharma ltd - sulpiride - oral solution - 40mg/1ml

Israel - Inggris - Ministry of Health

padagis israel pharmaceuticals ltd, israel - clotrimazole - vaginal cream - clotrimazole 2 % - clotrimazole - clotrimazole - broad spectrum antimycotic with fungicidal action

Uni Eropa - Inggris - EMA (European Medicines Agency)

teva pharma b.v. - docetaxel - carcinoma, non-small-cell lung; breast neoplasms; prostatic neoplasms - antineoplastic agents - breast cancerdocetaxel teva pharma monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent.non-small-cell lung cancerdocetaxel teva pharma is indicated for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer after failure of prior chemotherapy.docetaxel teva pharma in combination with cisplatin is indicated for the treatment of patients with unresectable, locally advanced or metastatic non-small-cell lung cancer, in patients who have not previously received chemotherapy for this condition.prostate cancerdocetaxel teva pharma in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone refractory metastatic prostate cancer.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - bortezomib, quantity: 3.5 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections; mannitol - bortezomib ever pharma, in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy. bortezomib ever pharma, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma. bortezomib ever pharma is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease. bortezomib ever pharma in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - bortezomib, quantity: 2.5 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections; mannitol - bortezomib ever pharma, in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy. bortezomib ever pharma, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma. bortezomib ever pharma is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease. bortezomib ever pharma in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma.

Belgia - Inggris - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

essential pharma (m) ltd. - clobazam 1 mg/ml - oral suspension - 1 mg/ml - clobazam 1 mg/ml - benzodiazepine derivatives